Advertisement
Advertisement

VRNA

VRNA logo

Verona Pharma plc

105.15
USD
+0.06
+0.06%
Aug 01, 16:00 UTC -4
Closed
exchange

After-Market

105.25

+0.10
+0.09%

Verona Pharma plc Profile

Info & Links

CEO

David Zaccardelli

Headquarters

3 MORE LONDON RIVERSIDE
LONDON, X0 SE1 2RE, UNITED KINGDOM

Sector

Medical

Auditor

Ernst & Young LLP

Share holders

--

Employees

209

Verona Pharma plc Statistics

Valuation Measures

Market Capitalization2

8.96B

Enterprise Value

8.80B

Enterprise Value/EBITDA(ttm)

-65.30

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

--

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

70.08%

Operating Margin(ttm)

--

Profit Margin(ttm)

-219.40%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

-55.43%

Return on Assets(ttm)

--

Income Statement

Revenue(ttm)

118.53M

Revenue Per Share(ttm)

1.39

Gross Profit(ttm)

112.55M

EBITDA(ttm)3

-134.78M

Net Income Available to Common(ttm)

-163.94M

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

--

52-Week Change

364.05%

S&P 500 52-Week Change

14.53%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

85.13M

Dividend Yield

--

Float4

--

% Held by Insiders

--

% Held by Institutions

--

Balance Sheet

Total Cash(mrq)

401.42M

Total Cash Per Share(mrq)

4.72

Total Debt(mrq)

241.74M

Total Debt/Equity(mrq)

106.68%

Current Ratio(mrq)

8.86%

Quick Ratio(mrq)

--

Book Value Per Share(mrq)

2.66

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.14

Free Cash Flow(ytd)

-12.10M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement